Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Neurology ; 271 (2023), 1. - S. 141-176. - ISSN 0340-5354. - eISSN 1432-1459
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2023
- Urheber
-
Kümpfel, Tania
Giglhuber, Katrin
Aktas, Orhan
Ayzenberg, Ilya
Bellmann-Strobl, Judith
Häußler, Vivien
Havla, Joachim
Hellwig, Kerstin
Hümmert, Martin W.
Jarius, Sven
Kleiter, Ingo
Klotz, Luisa
Krumbholz, Markus
Paul, Friedemann
Ringelstein, Marius
Ruprecht, Klemens
Senel, Makbule
Stellmann, Jan-Patrick
Bergh, Florian Then
Trebst, Corinna
Tumani, Hayrettin
Warnke, Clemens
Wildemann, Brigitte
Berthele, Achim
- DOI
-
10.18725/OPARU-54218
- URN
-
urn:nbn:de:bsz:289-oparu-54294-6
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kümpfel, Tania
- Giglhuber, Katrin
- Aktas, Orhan
- Ayzenberg, Ilya
- Bellmann-Strobl, Judith
- Häußler, Vivien
- Havla, Joachim
- Hellwig, Kerstin
- Hümmert, Martin W.
- Jarius, Sven
- Kleiter, Ingo
- Klotz, Luisa
- Krumbholz, Markus
- Paul, Friedemann
- Ringelstein, Marius
- Ruprecht, Klemens
- Senel, Makbule
- Stellmann, Jan-Patrick
- Bergh, Florian Then
- Trebst, Corinna
- Tumani, Hayrettin
- Warnke, Clemens
- Wildemann, Brigitte
- Berthele, Achim
- Universität Ulm
Entstanden
- 2023
Ähnliche Objekte (12)
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica
The Gut Microbiome in Neuromyelitis Optica
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
The history of neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica